Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.105-3.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.73% | 1.50% | -3.60% | -33.07% | -33.71% |
| Total Depreciation and Amortization | -7.37% | 1.70% | 0.89% | -0.65% | -8.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.17% | -36.45% | -39.57% | 81.40% | 85.43% |
| Change in Net Operating Assets | 172.89% | 234.64% | -112.57% | -167.32% | -203.17% |
| Cash from Operations | 5.47% | -3.90% | -26.08% | -51.84% | -51.04% |
| Capital Expenditure | 83.95% | 19.23% | -104.76% | -261.54% | -145.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.13% | 67.40% | 229.62% | 195.60% | -1,423.71% |
| Cash from Investing | 68.15% | 67.33% | 229.47% | 195.44% | -1,412.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,044.37% | 288.66% | 31.91% | -92.71% | -92.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -12.79% | 87.52% | 100.00% | 100.00% |
| Cash from Financing | 1,041.63% | 290.92% | 32.44% | -92.68% | -92.62% |
| Foreign Exchange rate Adjustments | -132.67% | -147.86% | 388.17% | 184.98% | 156.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.99% | 228.75% | 1,025.86% | -83.50% | -184.89% |